AstraZeneca: BREZTRI is now available in the US, making it the first and only fixed-dose triple therapy for asthma patients aged 12 and above.

Zhitongcaijing · 3d ago
AstraZeneca: BREZTRI is now available in the US, making it the first and only fixed-dose triple therapy for asthma patients aged 12 and above.